StockData
Nuvation Bio Inc. logo

Nuvation Bio Inc. (NUVB) stock

NUVBNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30107% above fair value
$3.90+0.06 (+1.56%)

Close on Nov 17, 2026Market cap $1.37BP/E –Yield –

Nuvation Bio gross margin

Gross margin is gross profit as a percentage of revenue.

Nuvation Bio's gross margin for the twelve months ending Sep 30, 2025 was 54.3%. For fiscal 2024 it was 10.1%.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 202410.1%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2025Sep 30, 202574.5%+182.9
Q2 FY2025Jun 30, 202546.7%+40.6
Q1 FY2025Mar 31, 202532.1%–
Q4 FY2024Dec 31, 202426.2%–
Q3 FY2024Sep 30, 2024-108.4%–
Q2 FY2024Jun 30, 20246.1%–

More Nuvation Bio figures

See a number that looks wrong?